Cancer: Solid Tumours

Genomic Laboratory Hub Services

In May 2022, the latest version of the National Test Directory (NTD) for Cancer was published by NHSE; this sets out the national strategy for the genomic tests that are available for cancer diagnostics tests and the technologies by which testing will be delivered.

The NE&Y GLH solid tumour service is delivered by a regional team across the three genomic laboratory services. Details on how to order a test are described below.

Cancer genomics diagnostics are funded centrally by NHSE and so referring Trusts will not be charged for these services if they refer testing to their designated local GLH.

Note. Pathology activity is funded separately and will still be charged for.

The Cancer Team

Paul Roberts
Lead Scientist: Cancer

Alastair Greystoke
Clinical Lead: Oncology

Sally Lane
Clinical Lead: Pathology


Gavin Cuthbert

Laura Ions


Rebecca Pollitt

Mark Watson


Steve Morris

Julie Atkey

National Genomic Test Directory

The 2020/2021 National Genomic Test Directory for rare and inherited disorders and cancer.

View Directory
Genomic Laboratory Hub Services